Securities code: Guangdong Hybribio Biotech Co.Ltd(300639) securities abbreviation: Guangdong Hybribio Biotech Co.Ltd(300639) Announcement No.: 2022037
Guangdong Hybribio Biotech Co.Ltd(300639)
Announcement on correction of the notice on convening the 2021 annual general meeting of shareholders
The board of directors does not guarantee the truthfulness, completeness, or timely disclosure of any material information of the company.
On March 26, 2022, Guangdong Hybribio Biotech Co.Ltd(300639) (hereinafter referred to as “the company”) published in the securities times, China Securities Journal, Shanghai Securities News, securities daily and cninfo（ http://www.cn.info.com.cn. ）The notice on convening the 2021 annual general meeting of shareholders (Announcement No.: 2022034) was disclosed on the. After inspection, it is found that due to the negligence of the company’s staff, some contents of “I. Basic information of holding the meeting” in the above announcement need to be corrected, as follows:
Before and after correction
6. Equity registration date of the meeting: April 11, 2021 (star 6. Equity registration date of the meeting: April 11, 2022) (Monday)
7. Attendees 7. Attendees
(1) As of April 11, 2021 (star) (1) as of April 11, 2022 (Monday) at 15:00, the closing time of Shenzhen Stock Exchange, and at 15:00, the closing time of Shenzhen Stock Exchange, All the companies registered in the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited and the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited have issued voting shares, and all the shareholders of the companies registered in the register of the company have issued voting shares, and all the shareholders have the right to attend the general meeting of shareholders, And may entrust an agent to attend the meeting and participate in voting in written form. The shareholder’s agent does not have to be a shareholder of the company for the resolution; A shareholder’s agent need not be a shareholder of the company;
In addition to the above corrections, other contents of the notice on convening the 2021 annual general meeting of shareholders (Announcement No.: 2022034) remain unchanged.
The corrected notice on convening the 2021 annual general meeting of shareholders is detailed in the annex.
The company will further strengthen the review of announcement documents in the preparation process, improve the quality of information disclosure and avoid similar situations. The Company Apologizes for the inconvenience caused to investors by this correction announcement, and asks the majority of investors for understanding.
It is hereby announced.
Guangdong Hybribio Biotech Co.Ltd(300639) board of directors
March 28, 2002
enclosure:
Guangdong Hybribio Biotech Co.Ltd(300639)
Notice on convening the 2021 annual general meeting of shareholders (after correction)
The company and all members of the board of directors guarantee that the information disclosed is true, accurate, timely and complete without false records, misleading statements or major omissions.
1、 Basic information of the meeting
1. Session of the general meeting of shareholders: Guangdong Hybribio Biotech Co.Ltd(300639) (hereinafter referred to as “the company”) 2021 annual general meeting of shareholders
2. Convener of the general meeting of shareholders: the board of directors of the company
3. Legality and compliance of the meeting: the 33rd meeting of the Fourth Board of directors held on March 24, 2022 deliberated and adopted the proposal on convening the 2021 annual general meeting of shareholders of the company. The convening procedures of the meeting comply with relevant laws, regulations and the relevant provisions of Guangdong Hybribio Biotech Co.Ltd(300639) articles of Association.
4. Meeting time:
(1) On site meeting time: 15:00, April 15, 2022 (Friday)
(2) Online voting time:
① Online voting time of trading system of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”): 9:15 to 9:25 on April 15, 2022; 9: 30 to 11:30; 13: 00 to 15:00;
② Shenzhen Stock Exchange Internet voting system（ http://wltp.cn.info.com.cn. ）Voting time: any time from 9:15 to 15:00 on April 15, 2022.
5. Meeting mode: the combination of on-site voting and online voting.
(1) On site voting: shareholders attend the on-site meeting in person or entrust others to attend and vote at the on-site meeting through a power of attorney (see Annex I);
(2) Online voting: shareholders shall log in to the trading system of Shenzhen Stock Exchange or the Internet voting system of Shenzhen Stock Exchange within the online voting time announced in this announcement（ http://wltp.cn.info.com.cn. ）Vote.
Shareholders of the company can only choose one of on-site voting and online voting. In case of repeated voting of the same voting right, the first voting result shall prevail.
6. Equity registration date of the meeting: Monday, April 11, 2022
7. Meeting attendees
(1) As of 15:00 on Monday, April 11, 2022, when the Shenzhen Stock Exchange closes, all shareholders of the company’s issued voting shares registered in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. have the right to attend the general meeting of shareholders and can entrust an agent in writing to attend the meeting and vote. The shareholder agent does not have to be a shareholder of the company;
(2) Directors, supervisors and senior managers of the company;
(3) Lawyers and other relevant personnel employed by the company.
8. Venue of the on-site meeting: the company’s conference room (community D 5-3-3-4, high tech Zone, north of Chaozhou Economic Development Experimental Zone, Guangdong Province).
2、 Matters considered at the meeting
(I) name of deliberation proposal
remarks
Proposal code proposal name (the column checked in this column can vote)
100 total proposal √
Non cumulative voting proposal
1.00 proposal on the work report of the board of directors in 2021 √
2.00 proposal on the work report of the board of supervisors in 2021 √
3.00 proposal on financial statement report of 2021 √
4.00 proposal on the special report on the deposit and use of raised funds in 2021 √
5.00 proposal on special report on funds occupied by controlling shareholders and other related parties √
6.00 proposal on 2021 profit distribution and conversion of capital reserve into share capital √
7.00 proposal on changing the registered capital of the company and amending the articles of association √
8.00 proposal on 2021 annual report and its summary √
9.00 proposal on the remuneration scheme of directors and supervisors in 2022 √
10.00 proposal on applying for comprehensive credit line from banks √
11.00 proposal on reappointment of 2022 audit institution √
(II) disclosure
The above proposals have been deliberated and adopted at the 33rd meeting of the Fourth Board of directors and the 28th meeting of the Fourth Board of supervisors respectively. For details, please refer to cninfo.com on March 26, 2022（ http://www.cn.info.com.cn. ）Relevant announcements of disclosure.
(III) special emphasis
Proposal 6 is the premise for the effectiveness of proposal 7. Both proposal 6 and proposal 7 are special resolutions of the general meeting of shareholders and need to be passed by more than 2 / 3 of the votes held by shareholders (including shareholders’ agents) attending the general meeting of shareholders.
Proposals 4-6 and 8-11 are major issues that affect the interests of small and medium-sized investors. The company will vote for small and medium-sized investors (except shareholders who individually or jointly hold more than 5% of the company’s shares and other shareholders other than directors, supervisors and senior managers of the company), count their votes separately, and make public disclosure according to the vote counting results.
Independent directors will report on their work at this annual general meeting of shareholders. The report on the work of independent directors is published on the company’s designated information disclosure website cninfo.com.cn.
3、 On site meeting registration method
1. Registration method
(1) Corporate shareholders shall be represented at the meeting by their legal representatives or their entrusted agents. If the legal representative attends the meeting, he shall go through the registration formalities with the copy of the business license stamped with the official seal, the certificate of legal representative and ID card; If a legal person shareholder entrusts an agent to attend the meeting, the agent shall go through the registration formalities with his own ID card, a copy of the business license stamped with the official seal and the power of attorney;
(2) If a natural person shareholder attends the meeting in person, he / she shall go through the registration formalities with his / her ID card and shareholder account card; If a natural person shareholder entrusts an agent to attend, the agent shall go through the registration formalities with his own ID card, power of attorney, client’s shareholder account card and copy of client’s ID card;
(3) Non local shareholders can register by letter or fax with the above relevant certificates, and carefully fill in the shareholder participation registration form (see Annex II) for registration confirmation;
(4) Telephone registration is not accepted for this meeting.
2. Registration time: the on-site registration time of this general meeting of shareholders is 14:00-15:00 p.m. on Friday, April 15, 2022; Those registered by letter or fax must be delivered or faxed to the company before 17:00 p.m. on Thursday, April 14, 2022.
3. Registration place: Guangdong Hybribio Biotech Co.Ltd(300639) conference room, community D 5-3-3-4, high tech Zone, north of Chaozhou Economic Development Experimental Zone, Guangdong Province.
4. Meeting contact information
Contact: Chen Yi, Yuan Xian
Tel: 07682852923
Fax No.: 07682852920
Mailing address: Community D 5-3-3-4, high tech Zone, north of Chaozhou Economic Development Experimental Zone, Guangdong Province
5. Other precautions:
(1) Shareholders and shareholders’ agents attending the on-site meeting shall bring the original of relevant certificates to the venue half an hour before the meeting to go through the registration formalities.
(2) The on-site meeting of the general meeting of shareholders will last for half a day, and the accommodation, transportation and other expenses of the participants shall be borne by themselves. 5、 Specific operation process of participating in online voting
In this shareholders’ meeting, the company provides shareholders with an online voting platform. Shareholders can vote through the trading system of Shenzhen Stock Exchange or the Internet voting system (website) http://wltp.cn.info.com.cn. ）See Annex III for the specific operation process of online voting.
6、 Documents for future reference
1. Resolution of the 33rd meeting of Guangdong Hybribio Biotech Co.Ltd(300639) the 4th board of directors; 2. Resolution of the 28th meeting of Guangdong Hybribio Biotech Co.Ltd(300639) the 4th board of supervisors. It is hereby announced.
Guangdong Hybribio Biotech Co.Ltd(300639) board of directors March 26, 2002
Annex I: power of attorney Annex II: shareholder participation registration form Annex III: specific operation process of online voting
Annex I:
Power of attorney
Guangdong Hybribio Biotech Co.Ltd(300639) ：
This
